You are here:

Vimpat 50mg X 14 tablets back in stock

Published on

Updated:

Nicola Swanborough

Vimpat 50mg X 14 tablets back in stock

Back in June we reported a short-term stock outage of Vimpat (lacosamide) 50mg x 14 tablets. This was due to delays in production at the pharmaceutical company’s external manufacturing site.

UCB is pleased to announce that the problem has been resolved and the product is now back in stock.

LET'S STAY IN TOUCH...

We send monthly e-newsletters to keep you informed with tips for managing epilepsy, the latest news, inspirational stories, fundraising opportunities and further information from Epilepsy Society.

Read our privacy policy

It is always your choice as to whether you want to receive information from us. You may opt-out of our marketing communications by clicking the ‘unsubscribe’ link at the end of our marketing emails or through our unsubscribe number 01494 601 300.